Jiuzhitang Co. Hits Day Low of CNY 8.30 Amid Price Pressure

Jiuzhitang Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant decline today, with its stock price dropping by 5.3%. The stock reached an intraday low of CNY 8.30, reflecting ongoing challenges in its financial performance. Over the past year, Jiuzhitang has underperformed the broader market, generating a return of just 1.26% compared to the China Shanghai Composite's 16.08%. The company's recent financial results indicate a troubling trend, with net sales falling by 19.13% and a notable decline in pre-tax profit, which decreased by 58.23%. Additionally, net profit plummeted by 80.07%, marking the eleventh consecutive quarter of negative results. Jiuzhitang's long-term growth prospects appear limited, as evidenced by a five-year annual decline in net sales of 11.36% and an operating profit decrease of 21.52%. With a market capitalization of CNY 5,915 million, Jiuzhitang's current P/E ratio stands at 52.00, while its dividend yield is reported at 4.34%. The company's return on equity is relatively low at 3.89%, further highlighting the challenges it faces in the competitive pharmaceutical landscape.